Aurora Cannabis Inc. (TSE:ACB - Get Free Report) Senior Officer Andre Jerome bought 8,000 shares of the stock in a transaction on Friday, June 20th. The stock was purchased at an average price of C$5.83 per share, for a total transaction of C$46,640.00.
Aurora Cannabis Stock Up 1.9%
TSE ACB traded up C$0.10 on Tuesday, reaching C$5.47. The stock had a trading volume of 763,800 shares, compared to its average volume of 537,665. The business has a 50 day moving average price of C$6.96 and a 200 day moving average price of C$6.69. The company has a current ratio of 3.42, a quick ratio of 2.48 and a debt-to-equity ratio of 18.72. Aurora Cannabis Inc. has a 1 year low of C$4.95 and a 1 year high of C$9.90. The company has a market capitalization of C$299.25 million, a price-to-earnings ratio of -6.75 and a beta of 2.71.
Aurora Cannabis Company Profile
(
Get Free Report)
Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael '71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Aurora Cannabis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aurora Cannabis wasn't on the list.
While Aurora Cannabis currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
